Amsterdam
Netherlands
5
2024-10-10
4
2025-01-21
These are the the leading inventors for applications assigned to Self-screen B.V.:
Self-screen B.V. based in Amsterdam, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methylation classifier for detection of HPV-induced invasive cancers, nonHPV-induced gynaecological and anogenital cancers and their high-grade precursor lesions
#2 | 2020-01-30 ✅ Patent 11,932,909 granted on 2024-03-19Methylation classifier for detection of HPV-induced invasive cancers, nonHPV-induced gynaecological and anogenital cancers and their high-grade precursor lesions
#3 | 2015-10-08 ✅ Patent 9,890,432 granted on 2018-02-13PRDM14 and FAM19A4, molecular diagnostic markers for HPV-induced invasive cancers and their high-grade precursor lesions
#4 | 2015-08-13METHYLATION ANALYSIS ON SELF-SAMPLES AS TRIAGE TOOL FOR HPV-POSITIVE WOMEN
#5 | 2010-12-02 ✅ Patent 9,435,001 granted on 2016-09-06Detection method for cervical HPVS
Also check out SELF-SCREEN B.V.'s (Amsterdam, Netherlands) applicant profile with 3 patent applications submitted.
97043 ⎘